Carreno, F R
Donegan, J J
Boley, A M
Shah, A
DeGuzman, M
Frazer, A
Lodge, D J
Article History
Received: 17 April 2015
Revised: 8 September 2015
Accepted: 14 October 2015
First Online: 1 December 2015
Competing interests
: Dr Frazer has served on advisory boards for Lundbeck and for Takeda Pharmaceuticals International, Inc and Eli Lilly and Co., and as a consultant for Dey Pharmaceuticals. Dr Lodge reports receiving consulting fees from Dey Pharmaceuticals.